Recursion Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
RXRX
CUSIP
75629V104
Type
Equity
Class
CL A
Num filings
363
Total reported value, excl. options
$1.58 B
Manager Report Date Value ($000) Shares Option Type